The initiation and development of neuroblastoma are underpinned by crucial genetic factors, including but not limited to MYCN amplifications, MDM2 amplifications or overexpression [5], ALK mutations or amplifications, and segmental chromosomal abnormalities [6]. This evidence concerns the gene MYCN and neuroblastoma.